In this week’s issue:
- Burroughs Wellcome Fund – Investigators in the Pathogenesis of Infectious Disease (final reminder)
- UBC Office of the Provost and Vice-President Academic – Teaching and Learning Enhancement Fund (4 attachments)
- Prostate Cancer Foundation – 2014 Young Investigator Awards
- Canadian Blood Services – Graduate Fellowship Program
- The Leukemia & Lymphoma Society – Screen to Lead Program
- London Health Sciences Foundation – The Allen-Carey Education Award of Excellence in Women’s Health
- Canadian Institutes of Health Research/National Institutes of Health (NIH) – Quantitative Imaging Network Research Program (QIN)
Awards and Honours:
- 2014 Warren Alpert Foundation Prize
- Taubman Medical Research Institute – 2014 Taubman Prize
- Centre for Blood Research – Seminar Series: Some considerations in coagulation and its control
- Gairdner Symposium (reminder)
Faculty of Medicine Internal Deadline: October 18, 2013
Deadline: November 1, 2013
Five-year awards provide $500,000 to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects that hold potential for significantly advancing the biochemical, pharmacological, immunological, and molecular biological understanding of how microbes and the human body interact.
Faculty of Medicine Internal Deadline: November 8, 2013
The following documents related to the 2014-2015 Teaching and Learning Enhancement Fund (TLEF) are sent on behalf of Dr. David Snadden, Executive Associate Dean, Education:
(i) Memorandum –TLEF 2014-2015 –
(ii) TLEF Call for Proposals issued by the Office of Vice Provost and AVP Academic Proposals 2014-15
Applicants are asked to carefully review the TLEF Criteria (http://tlef.ubc.ca/tlef-critera/) and the Application Procedures(http://tlef.ubc.ca/application-process/) as there have been some important changes added for this year.
Please note the internal deadline for submission of proposals is 4:00 pm, Friday, November 8, 2013.
Submit one (1) complete & signed proposal via e-mail or mail to:
Ms. Vanessa Ho
Office of the Executive Associate Dean Education
UBC Faculty of Medicine
11th floor, Gordon & Leslie Diamond Health Care Ctr.
2775 Laurel Street
Vancouver, B.C. V5Z 1M9
Tel: (604) 875-4111 Extn. 67802
Deadline: November 13, 2013
PCF Young Investigator awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. This, for example, includes funding “protected time” or direct costs for experiments.
Documentation of an equal in-kind level of support will be requested in the form of dedicated space, equipment, institutional overhead, core institutional resources, etc. The documentation required is a letter from the Cancer Center Director or Departmental Chairperson which confirms institutional commitment to the career development of the PCF Young Investigator while under the direct supervision of a Mentor. Mentorship is required for every PCF Young Investigator applicant and grantee. Young Investigator awardees and their Mentors will be required to attend the annual PCF Scientific Retreat in October 2014.
Please visit www.pcfscience.org to apply.
Deadline: November 15, 2013
Canadian Blood Services offers a Graduate Fellowship Program to attract and support young investigators to initiate or continue training in the field of blood transfusion science. This program is offered to graduate students who are undertaking full-time research training in a Canadian graduate school leading to a Ph.D. degree.
The fellowship has a value of $21,000 per annum. A yearly research and travel allowance of $1,000 per annum is provided with each fellowship. Students may be supported for a maximum of 4 years. The initial term of the fellowship is 2 years with possible renewal for an additional 2 years upon reapplication.
Please see the CBS website for full details.
Deadline: December 15, 2013; 3pm ET
The Leukemia & Lymphoma Society (LLS) is sponsoring and issuing this Request for Applications (RFA) from qualified academic laboratories for drug discovery support specifically directed towards medicinal chemistry and/or drug target screening in hematological malignancies. LLS recognizes a significant need for investigators to receive resources for high-throughput screening and optimization of small molecules into drug-like compounds suitable for in vivo testing in a disease-relevant model that can be used for further preclinical proof-of-concept testing of the new drug target. Last year, the first year of this new funding mechanism, 6 projects were chosen for funding by an acclaimed peer review panel. This year, new laboratories/projects will be selected to participate in this model of collaboration whereby LLS, grantee, sponsoring institution and appropriate contract service organizations (CROs) or core facilities at academic institutions work together to develop compounds with the potential to change the standard of care for patients with blood cancer. Continued funding/sponsorship will be contingent on available funds and assessments of progress toward the goals outlined in each individual proposal accepted by LLS.
Deadline: February 1, 2014
The Allen-Carey Education Award of Excellence in Women’s Health was established in 1998. The award supports unique training opportunities for specialized education in women’s health, positioning exceptional individuals to succeed as future leaders in women’s health.
Priority will be given to unique training opportunities such as an additional year of training associated with a fellowship program. In general, the award is not intended to fund fellowship training, preceptor experiences, or additional clinical training that could be offered as part of a residency training program.
Funding is for a proposed period of study starting July 1 of the year the funds are awarded to June 30 of the following year. London Health Sciences Foundation will release funds to successful applicants. The applicant should indicate the timelines of the proposed training experience and provide justification if the proposed study period is different from the July 1 to June 30 timeframe.
Annually, $40,000 will be awarded from the Allen-Carey fund to the successful candidate.
Please see website for further details.
Deadline: February 2014
The Institute of Cancer Research (ICR) in partnership with the National Cancer Institute of the NIH is pleased to announce the upcoming launch of a new funding opportunity to enable Canadian participation in the Quantitative Imaging Network (QIN) established by the National Cancer Institute (NCI) of the National Institutes of Health (NIH). This partnership between US and Canadian researchers will promote research on quantitative imaging for prediction and measurement of tumour response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making and personalized medicine approaches.
The NCI has already established a Quantitative Imaging network (QIN) that currently has 17 research teams across the US that share ideas and approaches to validate and standardize imaging data and related imaging metadata for quantitative measurements of responses to cancer therapies. The goal of this current initiative is enable the Canadian cancer imaging research community to establish up to two Canadian teams as an integral part of QIN.
Detailed instructions on how to submit a full application will be posted on the CIHR website at the time of the full call announcement in the near future.
For more information about the competition details, please consult the National Institutes of Health website.
For more information about Canadian participation in this initiative, please contact Dr. Judith Bray at Judith.email@example.com
AWARDS AND HONOURS:
Deadline: November 1, 2013
The Warren Alpert Foundation Prize recognizes and honors one or more scientists whose achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease.
The unrestricted cash award accompanying the prize for 2014 is $250,000, a citation and plaque.
For questions, please contact Edward_canton@hms.harvard.edu. Please also visit the Warren Alpert Foundation Prize website at http://warrenalpert.org/home/. To nominate on-line, please visit http://alpertprize.hms.harvard.edu/nomination/.
Deadline: February 1, 2014
In June, the A. Alfred Taubman Medical Research Institute at the University of Michigan awarded the second annual $100,000 Taubman Prize for Translational Medical Science to Dr. Brian Druker of the Oregon Health & Science University, and Dr. Charles Sawyers of the Memorial Sloan-Kettering Cancer Center. They are honored for their research which has transformed chronic myeloid leukemia from a routinely fatal disease to a manageable condition.
The prize was established in 2011 to recognize the clinician-scientists making the most significant contribution to translating basic research findings into medical practice. Each year, a new recipient will be presented the prize and asked to serve as the keynote speaker at the Taubman Institute’s annual symposium, which in 2014 is scheduled for Oct. 10.
A panel of nationally prominent clinician-scientists will judge nominees based on their contribution to translating basic research findings into clinical applications and by the manner in which their clinical practice connects to their research. All clinician-scientists, regardless of country, are eligible, excluding U-M researchers.
Contest rules and nomination forms can be found at: http://www.taubmaninstitute.org/taubman-prize
Date: October 10th, 2013, 11am-12pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall
Dr. Elliot Chaikof
Johnson and Johnson Professor of Medicine, Harvard Medical School
Chairman, Roberta and Stephen R. Weiner Department of Surgery
Surgeon-in-Chief, Beth Israel Deaconess Medical Center
Wyss Institute of Biologically Inspired Engineering of Harvard University
Sandwiches and refreshments will be served at 10:55am.
Watch online: http://meetingfomubc.adobeconnect.com/CBRseminar/
Date: October 21, 2013; 4– 6pm
Location: Life Sciences Centre, Lecture Theatre 2 (LSC 2), UBC, 2350 Health Sciences Mall
Don’t miss this opportunity to listen to two dynamic and high profiled researchers at the 2013 Gairdner Vancouver Symposium.
This free public lecture will feature:
Dr. Nasmyth [2007 Canada Gairdner International Award Recipient]
Presentation title: How are chromosomes held together?
Sir Winter [2013 Canada Gairdner International Award Recipient]
Presentation title: The antibody revolution: new pharmaceuticals for a new age
More information about the symposium can be found at http://www.cmmt.ubc.ca/events/2013/10/2013-gairdner-foundation-symposium
More information about the Gairdner Foundation can be found at http://www.gairdner.org/
For questions or more information please contact Seetha at firstname.lastname@example.org